欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/2207/001
药品名称
Hydroxocobalamin G.L. Pharma
活性成分
hydroxocobalamin 1.0 mg/ml
剂型
Solution for injection
上市许可持有人
G.L. Pharma GmbH, Austria
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Iceland (IS)
Norway (NO)
Finland (FI)
Hydroxocobalamin Pharmexon
许可日期
2023/01/24
最近更新日期
2024/06/12
药物ATC编码
B03BA03 hydroxocobalamin
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220202000019
Date of last change:2024/09/06
Final PL
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220202000019_2
Date of last change:2024/09/06
PubAR
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220202000019_3
Date of last change:2024/09/06
PubAR Summary
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220202000019_4
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase